ID PAFA_CANLF Reviewed; 444 AA. AC Q28262; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 1. DT 27-MAR-2024, entry version 122. DE RecName: Full=Platelet-activating factor acetylhydrolase; DE Short=PAF acetylhydrolase; DE EC=3.1.1.47 {ECO:0000250|UniProtKB:Q13093}; DE AltName: Full=1-alkyl-2-acetylglycerophosphocholine esterase; DE AltName: Full=2-acetyl-1-alkylglycerophosphocholine esterase; DE AltName: Full=LDL-associated phospholipase A2; DE Short=LDL-PLA(2); DE AltName: Full=PAF 2-acylhydrolase; DE Flags: Precursor; GN Name=PLA2G7; OS Canis lupus familiaris (Dog) (Canis familiaris). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis. OX NCBI_TaxID=9615; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Spleen; RX PubMed=7592717; DOI=10.1074/jbc.270.43.25481; RA Tjoelker L.W., Eberhardt C., Unger J., le Trong H., Zimmerman G.A., RA McIntyre T.M., Stafforini D.M., Prescott S.M., Gray P.W.; RT "Plasma platelet-activating factor acetylhydrolase is a secreted RT phospholipase A2 with a catalytic triad."; RL J. Biol. Chem. 270:25481-25487(1995). CC -!- FUNCTION: Lipoprotein-associated calcium-independent phospholipase A2 CC involved in phospholipid catabolism during inflammatory and oxidative CC stress response (By similarity). At the lipid-aqueous interface, CC hydrolyzes the ester bond of fatty acyl group attached at sn-2 position CC of phospholipids (phospholipase A2 activity) (By similarity). CC Specifically targets phospholipids with a short-chain fatty acyl group CC at sn-2 position. Can hydrolyze phospholipids with long fatty acyl CC chains, only if they carry oxidized functional groups (By similarity). CC Hydrolyzes and inactivates platelet-activating factor (PAF, 1-O-alkyl- CC 2-acetyl-sn-glycero-3-phosphocholine), a potent pro-inflammatory CC signaling lipid that acts through PTAFR on various innate immune cells CC (By similarity). Hydrolyzes oxidatively truncated phospholipids CC carrying an aldehyde group at omega position, preventing their CC accumulation in low-density lipoprotein (LDL) particles and CC uncontrolled pro-inflammatory effects (By similarity). As part of high- CC density lipoprotein (HDL) particles, can hydrolyze phospholipids having CC long-chain fatty acyl hydroperoxides at sn-2 position and protect CC against potential accumulation of these oxylipins in the vascular wall CC (By similarity). Catalyzes the release from membrane phospholipids of CC F2-isoprostanes, lipid biomarkers of cellular oxidative damage (By CC similarity). {ECO:0000250|UniProtKB:Q13093}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-O- CC alkyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:17777, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:30909, ChEBI:CHEBI:36707; EC=3.1.1.47; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17778; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-decyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-O- CC decyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:41376, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:78108, ChEBI:CHEBI:78109; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41377; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-dodecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-O- CC dodecyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:41372, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:78103, ChEBI:CHEBI:78104; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41373; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1- CC O-tetradecyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:41368, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:78101, ChEBI:CHEBI:78102; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41369; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1- CC O-hexadecyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:40479, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:44811, ChEBI:CHEBI:64496; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40480; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1- CC O-octadecyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:41183, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:52450, ChEBI:CHEBI:75216; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41184; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1- CC hexadecanoyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:41203, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:72998, ChEBI:CHEBI:75219; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41204; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-propionyl-sn-glycero-3-phosphocholine + H2O = CC 1-hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + propanoate; CC Xref=Rhea:RHEA:41191, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17272, ChEBI:CHEBI:72998, ChEBI:CHEBI:77831; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41192; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-butanoyl-sn-glycero-3-phosphocholine + H2O = CC 1-hexadecanoyl-sn-glycero-3-phosphocholine + butanoate + H(+); CC Xref=Rhea:RHEA:41195, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17968, ChEBI:CHEBI:72998, ChEBI:CHEBI:77832; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41196; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-pentanoyl-sn-glycero-3-phosphocholine + H2O = CC 1-hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + pentanoate; CC Xref=Rhea:RHEA:41199, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:31011, ChEBI:CHEBI:72998, ChEBI:CHEBI:77833; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41200; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-glutaroyl-sn-glycero-3-phosphocholine + H2O = CC 1-hexadecanoyl-sn-glycero-3-phosphocholine + glutarate + H(+); CC Xref=Rhea:RHEA:41159, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30921, ChEBI:CHEBI:72998, ChEBI:CHEBI:77756; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41160; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(5-oxopentanoyl)-sn-glycero-3-phosphocholine CC + H2O = 1-hexadecanoyl-sn-glycero-3-phosphocholine + 5-oxopentanoate CC + H(+); Xref=Rhea:RHEA:40483, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16120, ChEBI:CHEBI:72998, ChEBI:CHEBI:77890; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40484; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(9-oxononanoyl)-sn-glycero-3-phosphocholine + CC H2O = 1-hexadecanoyl-sn-glycero-3-phosphocholine + 9-oxononanoate + CC H(+); Xref=Rhea:RHEA:41179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:61042, ChEBI:CHEBI:72998, ChEBI:CHEBI:77812; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41180; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-[9-hydroperoxy-(10E-octadecenoyl)]-sn- CC glycero-3-phosphocholine + H2O = 1-hexadecanoyl-sn-glycero-3- CC phosphocholine + 9-hydroperoxy-10E-octadecenoate + H(+); CC Xref=Rhea:RHEA:41151, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:72998, ChEBI:CHEBI:77753, ChEBI:CHEBI:77754; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41152; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(10-hydroperoxy-8E-octadecenoyl)-sn-glycero- CC 3-phosphocholine + H2O = 1-hexadecanoyl-sn-glycero-3-phosphocholine + CC 10-hydroperoxy-(8E)-octadecenoate + H(+); Xref=Rhea:RHEA:41155, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, CC ChEBI:CHEBI:77749, ChEBI:CHEBI:77755; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41156; CC Evidence={ECO:0000250|UniProtKB:Q13093}; CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space CC {ECO:0000250|UniProtKB:Q13093}. Note=Associates with both LDL and HDL CC particles in plasma. Mainly associates with pro-inflammatory CC electronegative LDL particles. {ECO:0000250|UniProtKB:Q13093}. CC -!- TISSUE SPECIFICITY: Plasma. {ECO:0000250|UniProtKB:Q13093}. CC -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q13093}. CC -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U34246; AAC48484.1; -; mRNA. DR RefSeq; NP_001003198.1; NM_001003198.1. DR AlphaFoldDB; Q28262; -. DR SMR; Q28262; -. DR STRING; 9615.ENSCAFP00000058629; -. DR ESTHER; canfa-pafa; PAF-Acetylhydrolase. DR GlyCosmos; Q28262; 3 sites, No reported glycans. DR PaxDb; 9612-ENSCAFP00000030617; -. DR Ensembl; ENSCAFT00030011773.1; ENSCAFP00030010312.1; ENSCAFG00030006390.1. DR Ensembl; ENSCAFT00805027835; ENSCAFP00805021857; ENSCAFG00805015251. DR GeneID; 403848; -. DR KEGG; cfa:403848; -. DR CTD; 7941; -. DR eggNOG; KOG3847; Eukaryota. DR InParanoid; Q28262; -. DR OrthoDB; 3079661at2759; -. DR Proteomes; UP000002254; Unplaced. DR Proteomes; UP000694429; Chromosome 12. DR Proteomes; UP000694542; Unplaced. DR Proteomes; UP000805418; Unplaced. DR GO; GO:0034364; C:high-density lipoprotein particle; ISS:UniProtKB. DR GO; GO:0034362; C:low-density lipoprotein particle; ISS:UniProtKB. DR GO; GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; ISS:UniProtKB. DR GO; GO:0047499; F:calcium-independent phospholipase A2 activity; ISS:UniProtKB. DR GO; GO:0034638; P:phosphatidylcholine catabolic process; ISS:UniProtKB. DR GO; GO:0062234; P:platelet activating factor catabolic process; ISS:UniProtKB. DR GO; GO:0046469; P:platelet activating factor metabolic process; ISS:UniProtKB. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR016715; PAF_acetylhydro_eukaryote. DR PANTHER; PTHR10272; PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE; 1. DR PANTHER; PTHR10272:SF12; PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE; 1. DR Pfam; PF03403; PAF-AH_p_II; 1. DR PIRSF; PIRSF018169; PAF_acetylhydrolase; 1. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. DR PROSITE; PS00120; LIPASE_SER; 1. PE 2: Evidence at transcript level; KW Glycoprotein; HDL; Hydrolase; LDL; Lipid degradation; Lipid metabolism; KW Phospholipid degradation; Phospholipid metabolism; Reference proteome; KW Secreted; Signal. FT SIGNAL 1..21 FT /evidence="ECO:0000250" FT CHAIN 22..444 FT /note="Platelet-activating factor acetylhydrolase" FT /id="PRO_0000017831" FT ACT_SITE 274 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT ACT_SITE 297 FT /note="Charge relay system" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10037" FT ACT_SITE 352 FT /note="Charge relay system" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10037" FT CARBOHYD 60 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 200 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 424 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" SQ SEQUENCE 444 AA; 50136 MW; 814EF0AE38B074AC CRC64; MLPPKLHALF CLCSCLTLVH PIDWQDLNPV AHIRSSAWAN KIQALMAAAS IRQSRIPKGN GSYSVGCTDL MFDYTNKGTF LRLYYPSQED DHSDTLWIPN KEYFFGLSKY LGTPWLMGKI LSFFFGSVTT PANWNSPLRT GEKYPLIVFS HGLGAFRTIY SAIGIDLASH GFIVAAIEHR DGSASATYYF KDQSAAEIGN KSWSYLQELK PGDEEIHVRN EQVQKRAKEC SQALNLILDI DHGRPIKNVL DLEFDVEQLK DSIDRDKIAV IGHSFGGATV LQALSEDQRF RCGIALDAWM LPLDDAIYSR IPQPLFFINS ERFQFPENIK KMKKCYSPDK ERKMITIRGS VHQNFADFTF TTGKIVGYIF TLKGDIDSNV AIDLCNKASL AFLQKHLGLR KDFDQWDSLI EGKDENLMPG TNINITNEHD TLQNSPEAEK SNLD //